Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Po-An Lin, Chia-Yi Lee, Fu-Chin Huang, Jing-Yang Huang, Jia-Horung Hung & Shun-Fa Yang. (2020) Trend of Neovascular Glaucoma in Taiwan: A 15-year Nationwide Population-based Cohort Study. Ophthalmic Epidemiology 27:5, pages 390-398.
Read now
Read now
Andreas Katsanos, Kostantina Gorgoli, Dimitrios G. Mikropoulos, Esther Arranz-Marquez, Georgios P. Athanasopoulos, Miguel A. Teus & Anastasios G.P. Konstas. (2018) Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma. Expert Opinion on Biological Therapy 18:6, pages 719-724.
Read now
Read now
Articles from other publishers (21)
Ankit Srivastava, Biswajita PradhanBimal Prasad Jit, Kaushik Kumar Bharadwaj & Deeksha Rikhari. (2023) Advancement in Nanobiotechnology for Human Health Care: Focus on Ocular Diseases and Future Prospects. Current Nanomedicine 13:3, pages 147-158.
Crossref
Crossref
Masoud Rezaei, Mahsa Faramarzpour, Parnian Shobeiri, Homa Seyedmirzaei, Mohammad Sharifi Sarasyabi & Shahriar Dabiri. (2023) A systematic review, meta-analysis, and network analysis of diagnostic microRNAs in glaucoma. European Journal of Medical Research 28:1.
Crossref
Crossref
Elfriede Friedmann, Simon Dörsam & Gerd U. Auffarth. (2023) Models and Algorithms for the Refinement of Therapeutic Approaches for Retinal Diseases. Diagnostics 13:5, pages 975.
Crossref
Crossref
Dimitrios Kalogeropoulos, George Moussa, Velota Ct. Sung, Chrysavgi Pappa & Chris Kalogeropoulos. (2022) Neovascular Glaucoma: An Update. Klinische Monatsblätter für Augenheilkunde 240:03, pages 305-315.
Crossref
Crossref
Ling Bai, Yanfen Wang, Xindi Liu, Yuping Zheng, Wenjing Wang, Na He, Farheen Tariq, Feng Wang & Shu Zhang. (2022) The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma. Frontiers in Medicine 8.
Crossref
Crossref
Narine Viruni & Cindy X. Cai. 2022. Neovascular Glaucoma. Neovascular Glaucoma
121
130
.
Soumya Narayana, Mohammed Gulzar Ahmed, B. H. Jaswanth Gowda, Pallavi K. Shetty, Arfa Nasrine, M. Thriveni, Nadira Noushida & A. Sanjana. (2021) Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Aline de Cristo Soares Alves, Franciele Aline Bruinsmann, Silvia Stanisçuaski Guterres & Adriana Raffin Pohlmann. (2021) Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications. Molecules 26:14, pages 4127.
Crossref
Crossref
Heba Magdy Ahmed El-Saied & Mohamad Amr Salah Eddin Abdelhakim. (2021) Various modalities for management of secondary angle closure neovascular glaucoma in diabetic eyes: 1-year comparative study. International Ophthalmology 41:4, pages 1179-1190.
Crossref
Crossref
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia & Massimo Busin. (2020) Anti-VEGF Treatment in Corneal Diseases. Current Drug Targets 21:12, pages 1159-1180.
Crossref
Crossref
Hazem Helmy. (2020) Micropulse diode treatment in refractory neovascular glaucoma, high-energy level combined with adjunctive Ranibizumab. Egyptian Retina Journal 7:2, pages 41.
Crossref
Crossref
Anthony Mukwaya, Lasse Jensen, Beatrice Peebo & Neil Lagali. (2019) MicroRNAs in the cornea: Role and implications for treatment of corneal neovascularization. The Ocular Surface 17:3, pages 400-411.
Crossref
Crossref
Xinyue Zhao, Zhi Wang & Xiaobo Yang. (2017) Management of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy. Medicine 96:25, pages e7221.
Crossref
Crossref
Omar Saleh, Mark Ihnen & Shlomit Schaal. 2017. Drug Delivery. Drug Delivery
495
530
.
Vanessa Andrés-Guerrero, Lucía Perucho-González, Julián García-Feijoo, Laura Morales-Fernández, Federico Saenz-Francés, Rocío Herrero-Vanrell, Luis Pablo Júlvez, Vicente Polo Llorens, José María Martínez-de-la-Casa & Anastasios-Georgios P. Konstas. (2016) Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma. Advances in Therapy 34:2, pages 378-395.
Crossref
Crossref
Waled Mahdy Nada & Doaa Attia Abdel-Moety. (2017) Evaluation of Serum and Aqueous Humor Vascular Endothelial Growth Factor in Neovascular Glaucoma. Open Journal of Ophthalmology 07:02, pages 79-87.
Crossref
Crossref
Gustavo B. Rodrigues, Ricardo Y. Abe, Camila Zangalli, Savio L. Sodre, Flavia A. Donini, Danilo C. Costa, Andre Leite, Joao P. Felix, Marcelo Torigoe, Alberto Diniz-Filho & Homero Gusmão de Almeida. (2016) Neovascular glaucoma: a review. International Journal of Retina and Vitreous 2:1.
Crossref
Crossref
Yaoyao Sun, Yong Liang, Peng Zhou, Huijuan Wu, Xianru Hou, Zeqin Ren, Xiaoxin Li & Mingwei Zhao. (2016) Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmology 16:1.
Crossref
Crossref
Min Tang, Yang Fu, Ying Wang, Zhi Zheng, Ying Fan, Xiaodong Sun & Xun Xu. (2016) Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma. BMC Ophthalmology 16:1.
Crossref
Crossref
Mete GülerBurak BilginMusa ÇapkınAli ŞimşekŞemsettin Bilak. (2015) Assessment of Patient Pain Experience during Intravitreal 27-Gauge Bevacizumab and 30-Gauge Ranibizumab Injection. Korean Journal of Ophthalmology 29:3, pages 190.
Crossref
Crossref
Bin Wu, Haixiang Wu, Xiaoyan Liu, Houwen Lin & Jin Li. (2014) Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials. PLoS ONE 9:7, pages e101253.
Crossref
Crossref